Bourla has repeatedly stated that Pfizer might apply for emergency authorization from the FDA someday in October, essentially the most bold goal laid out by any of the vaccine builders whose photographs are actually in late-stage U.S trials.
His memo to employees Thursday sticks to that objective whereas additionally asserting Pfizer’s independence within the face of sturdy stress from the White Home to ship a shot earlier than Election Day.
“Now, we’re approaching our objective and regardless of not having any political concerns with our pre-announced date, we discover ourselves within the crucible of the U.S. Presidential election,” Bourla wrote, later including “we might by no means succumb to political stress.”
Trump final week stated he may block FDA’s proposal to strengthen its requirements for permitting emergency use of Covid-19 vaccines — requirements that will virtually actually rule out having a vaccine prepared to be used by early November. The president additionally accused FDA of performing primarily based on political concerns, fairly than science, with out providing any proof to help the declare.